Rush University Medical Center

Rush Preparing for COVID-19 Resurgence

Rush leaders, experts continue to plan for what pandemic could look in coming weeks and months

Newswise — With Chicago and Illinois seeing a surge in cases of COVID-19 and the city and state implementing new restrictions to lessen the spread of the disease, Rush University System for Health is preparing for a resurgence of cases. Rush will continue to diligently prepare and plan its response to the surge to ensure the safety of everyone in Rush hospitals and clinics and within the Rush community.

At Rush University Medical Center and across the Rush system, there has been a small increase in the number of patients hospitalized with COVID-19 so far, but it has not translated to an increase in mortality rates. Many of the new cases are in young adults who are less likely to develop severe symptoms and are able to recover at home.

“While we are cautiously optimistic that we will not experience the same high numbers of hospitalized patients that we experienced in the spring we are prepared for that scenario,” said Dr. Paul Casey, chief medical officer at Rush University Medical Center. “Our concern is patients will defer routine care which can be detrimental to one’s health so we are planning to remain open for all procedures, surgeries and appointments in order to care for all of our patients’ needs.”

In the face of adversity, Rush set the standard for COVID-19 care and received national recognition for its preparedness. In spring 2020, Rush was able to successfully care for the sickest COVID-19 patients, receiving hundreds of transfers from other hospitals that couldn’t provide the care patients needed, while maintaining safe and excellent care for the vast majority of patients who sought treatment from Rush for other medical conditions.

Even when positivity rates of COVID-19 tests began to fall, Rush leaders continued to meet to discuss what the future could bring. Because of this dedication to planning for the unknown, Rush has been able to ramp up its COVID-19 testing — the System has tested more than 90,000 people to date — and maintain a healthy level of personal protective equipment for staff, patients and visitors alike.

As a participant in multiple clinical trials, Rush has learned a significant amount about the most effective treatment for COVID-19. The development of the Illinois Department of Public Health’s resurgence plan has provided better regional tracking of cases and mitigation steps. In addition, Rush has helped hospitals throughout both the city and the country to be more prepared to care for patients with COVID-19.

“We know Rush is the place where people will come when they run out of options. Be assured that Rush will forever stand with patients in need,” said Dr. Omar Lateef, CEO of Rush University Medical Center. “We provide care safely for the vast majority of our patients who have conditions other than COVID-19 while also treating patients with the disease. We plan to continue to do so — offering the procedures, surgeries and all of the excellent care that our patients need.”

“Fortunately, we are in a very different place now compared to our initial surge in cases more than six months ago,” added Angelique Richard, PhD, RN, CENP, chief nursing officer, Rush University System for Health and Rush University Medical Center, and senior vice president of hospital operations, Rush University Medical Center. “COVID-19 testing is much more widely available, which not only contributes to the increase in reported cases, but also means people diagnosed with COVID-19 can take necessary precautions to prevent further spread.”

While Casey, Richard and the rest of Rush’s leadership team are planning for a challenging winter, Casey says basic common-sense public health approaches can make a big difference in reducing the impact of this second surge. Frequent hand washing, adhering to universal masking guidelines and social distancing are all scientifically proven methods to prevent the spread of COVID-19.  Staying home this winter also can greatly reduce your risk and the risk of infecting others.

“COVID-19 is among the greatest challenges Rush and the world have faced. We will get through this, because everyone at Rush has been exceptional, collaborative and resilient,” Casey said.  “When this challenge is behind us, and it will be, we will look back on it with immense pride at what we have done to save lives, improve health and protect our community.”




Filters close

Showing results

110 of 4156
Newswise: Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
23-Nov-2020 5:20 PM EST
Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
University of California San Diego

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread. New research suggests that that those suffering from economic hardships are less likely comply with new stay-at-home orders; however these same U.S. residents would be more likely to adhere to the new public health guidelines if their households received stimulus funds.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 9:15 AM EST Released to reporters: 30-Nov-2020 2:30 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 9:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded covid-19-update-surge-preparedness-vaccine-distribution
VIDEO
Released: 30-Nov-2020 2:20 PM EST
COVID-19 Update: Surge Preparedness, Vaccine Distribution
Cedars-Sinai

With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system's leaders say Cedars-Sinai is prepared.

Released: 30-Nov-2020 1:20 PM EST
Rethink COVID-19 infection control to keep primary schools open this winter, governments urged
BMJ

An urgent rethink of infection control policies to keep COVID-19 infection at bay in schools is needed if primary schools are to be kept open this winter, and the knock-on effects on their families avoided, argue children's infectious disease specialists in a viewpoint, published online in the Archives of Disease in Childhood.

Newswise: Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Released: 30-Nov-2020 12:45 PM EST
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health

Don’t Delay Your Care – Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care

Released: 30-Nov-2020 12:10 PM EST
Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
University of Leeds

Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus.

Released: 30-Nov-2020 11:30 AM EST
More than one-third of children with COVID-19 show no symptoms: study
University of Alberta Faculty of Medicine & Dentistry

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

Newswise: Promising lab results in quest to find naturally occurring anti-COVID therapies
24-Nov-2020 5:35 PM EST
Promising lab results in quest to find naturally occurring anti-COVID therapies
University of Alabama Huntsville

So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 have shown efficacy in ongoing first-batch testing at the University of Tennessee Health Science Center’s Regional Biocontainment Laboratory (UTHSC RBL) that’s the next step in the process to becoming a drug.

Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.


Showing results

110 of 4156

close
1.00919